Andiamo Revenue and Competitors

AI Treatment System for Cerebral Palsy. The Andiamo Treatment System involves a range of tools for a better family and clinician experience, including the Avanti SAAS platform which uses AI, automation, and digital twin simulation to design personalised treatments. The Ankle Treatment Range allows the clinician to use the Andiamo Tools and Avanti digital platform to digitally create a personalised prescription, create an AI digital twin that simulates the prescription outcome and it designs, using automation, a safe medical device. Using additive manufacturing, we manufacture and fit, a splint called an ankle foot orthosis or AFO. The next generation of treatments to be launched will have data sensors embedded to record compliance and activity that is fed back to the clinician, the family and the payer leading to real data outcomes and more valuable reimbursement data. Why Cerebral Palsy? Every 30 minutes a child is born with brain damage. Cerebral Palsy is brain damage at or before birth resulting in permanent disorders that affects every part of the body. In 2003 one of those children was Diamo, the son of the co-founders Naveed and Samiya's. This condition is underserved, neglected by business and is reimbursement friendly. Building a solution here allows us to build a scalable and repeatable value proposition that can serve many other chronic conditions The lifetime direct and indirect costs to a family of having cerebral palsy are over $1.2m. Reimbursement for children under 18 stars, on average, at $25k per year but can be much higher with medical negligence cases.